Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
DENVER, July 21, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group™ (NEO: MYCO)(OTC:MYCOF)(FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for ... [Read]